证券代码：300302 证券简称：同有科技 公告编号：2025-026 北京同有飞骥科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 北京同有飞骥科技股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日 召开第五届董事会第十次会议和第五届监事会第八次会议，于 2025 年 5 月 20 日 召开 2024 年年度股东大会，审议通过了《关于 2025 年度为全资子公司提供担保 额度预计的议案》。为满足全资子公司业务发展和经营需要，公司全资子公司鸿 秦（北京）科技有限公司（以下简称"鸿秦科技"）、湖南同有飞骥科技有限公司 （以下简称"湖南同有"）拟在未来 12 个月内分别向银行申请不超过 10,000 万 元的综合授信额度，授信种类包括但不限于流动资金贷款、保函、信用证、银行 承兑汇票等。由公司为上述银行授信提供担保，预计合计担保额度不超过 20,000 万元，担保额度有效期自 2024 年年度股东大会审议通过之日起 12 个月。具体内 容详见公司于 2025 年 4 月 29 日 ...

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300302 证券简称：同有科技 公告编号：2025-025 北京同有飞骥科技股份有限公司 关于公司向银行申请授信额度暨关联交易的公告 一、关联交易概述 北京同有飞骥科技股份有限公司（以下简称"公司"）于 2025 年 6 月 23 日 召开第五届董事会第十一次会议和第五届监事会第九次会议，审议通过了《关于 公司向银行申请授信额度暨关联交易的议案》。为更好地支持公司业务拓展，增 加流动性储备，公司拟向中国工商银行股份有限公司北京地安门支行（以下简称 "工商银行"）申请授信额度 1,000 万元，授信期限一年（具体起止日期以银行审 批为准），授信品种为短期流动资金贷款。 公司拟委托北京首创融资担保有限公司（以下简称"首创担保"）就上述银 行授信提供担保，同时，公司第一大股东、董事长兼总经理周泽湘先生就前述担 保向首创担保提供反担保连带责任保证。 根据《深圳证券交易所创业板股票上市规则》的规定，周泽湘先生为公司的 关联方，因此本次提供反担保连带责任保证事项构成关联交易，但不构成《上市 公司重大资产重组管理办 ...

证券代码：300302 证券简称：同有科技 公告编号：2025-023 北京同有飞骥科技股份有限公司 同时，公司申请授权公司法定代表人周泽湘先生全权代表公司办理、签署上 述授信额度内的有关合同、协议、凭证等各项法律文件。 第五届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 北京同有飞骥科技股份有限公司（以下简称"公司"）第五届董事会第十一 次会议于 2025 年 6 月 23 日在北京市海淀区地锦路 9 号院 2 号楼公司会议室以 现场表决和通讯表决相结合的形式召开。本次会议的通知已于 2025 年 6 月 20 日 以书面方式送达给所有董事。应出席本次会议的董事 7 人，实际出席本次会议的 董事 7 人。会议由董事长周泽湘先生主持，公司监事和高级管理人员列席了会 议。会议的召集、召开符合《中华人民共和国公司法》及《公司章程》的规定。 二、会议审议情况 1、审议通过《关于公司向银行申请授信额度暨关联交易的议案》 为更好地支持公司业务拓展，增加流动性储备，公司拟向中国工商银行股份 有限公司北京地安门支行申请授信额度 ...

证券代码：300302 证券简称：同有科技 公告编号：2025-024 北京同有飞骥科技股份有限公司 同时，公司申请授权公司法定代表人周泽湘先生全权代表公司办理、签署上 述授信额度内的有关合同、协议、凭证等各项法律文件。 根据《深圳证券交易所创业板股票上市规则》的规定，周泽湘先生为公司的 关联方，因此本次提供反担保连带责任保证事项构成关联交易。 第五届监事会第九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 北京同有飞骥科技股份有限公司（以下简称"公司"）第五届监事会第九次 会议于 2025 年 6 月 23 日在北京市海淀区地锦路 9 号院 2 号楼公司会议室以现 场表决的方式召开。本次会议的通知已于 2025 年 6 月 20 日通过书面方式送达所 有监事。应出席本次会议的监事 3 人，实际出席本次会议的监事 3 人。会议由监 事会主席杨大勇先生召集并主持，董事会秘书时志峰女士列席了会议。本次会议 采用现场书面方式表决，会议的召集、召开符合《中华人民共和国公司法》及《公 司章程》的规定。 二、会议审议情况 1、审议通过《关 ...

Investment Rating - The report rates the defense and military industry as "Overweight," indicating an expectation for the industry to outperform the overall market [3][29]. Core Insights - The report highlights that geopolitical uncertainties are increasing the valuation of the military industry, with expectations for quarterly performance to gradually materialize, potentially triggering a reversal in stock performance [2][6]. - The military industry is expected to see a gradual increase, particularly in June, driven by external geopolitical factors and the implementation of the 14th Five-Year Plan [6]. - The report emphasizes the importance of the military's fundamental changes, with stable order inflows expected to translate into performance improvements starting in Q2 [6]. - Key investment opportunities are identified in precision-guided weapons, underwater capabilities, AI/robotics, and traditional aircraft supply chains [6]. Market Review - The report notes that the Shenwan Defense and Military Index fell by 2.01%, while the CSI Military Leaders Index dropped by 2.83%, underperforming the Shanghai Composite Index, which fell by 0.51% [3][7]. - The report provides a detailed performance analysis of individual stocks within the military sector, highlighting the top gainers and losers for the week [14][15]. Valuation Changes - The report states that the current PE-TTM for the Shenwan Military Sector is 74.63, placing it in the upper range historically, with significant differentiation among sub-sectors [15][21]. - The report includes a valuation table for key military industry stocks, projecting future earnings and PE ratios [22].

Group 1 - The core point of the article is that shareholder Yang Yongsong plans to reduce his stake in the company by selling 4,792,637 shares, which represents 1.00% of the total share capital [1] - The share reduction will take place between June 5, 2025, and June 18, 2025, through centralized bidding transactions [1] - This reduction plan complies with relevant laws and regulations, as well as the company's internal policies, and will not affect the company's governance structure or ongoing operations [1] Group 2 - Yang Yongsong is not the controlling shareholder or actual controller of the company and does not hold any position within the company [1] - The implementation of this reduction plan will not lead to any changes in the company's control [1]

证券代码：300302 证券简称：同有科技 公告编号：2025-022 北京同有飞骥科技股份有限公司 关于持股 5%以上股东股份减持计划实施完成的公告 | 股东名 | 股份性质 | 本次减持前持有股份 占总股本 | | 本次减持后持有股份 占总股本 | | | --- | --- | --- | --- | --- | --- | | 称 | | 股数 | | 股数 | | | | | | 比例 | | 比例 | | 杨永松 | 合计持有股份 | 40,171,356 | 8.38% | 35,378,719 | 7.38% | | | 其中：无限售条件股份 | 40,171,356 | 8.38% | 35,378,719 | 7.38% | | | 有限售条件股份 | 0 | 0.00% | 0 0.00% | | 持股 5%以上的股东杨永松先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 北京同有飞骥科技股份有限公司（以下简称"公司"）于 2025 年 5 月 13 日 在巨潮资讯网（www.cni ...

证券代码：300302 证券简称：同有科技 公告编号：2025-021 北京同有飞骥科技股份有限公司 | 1、基本情况 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 信息披露义务人 | 杨永松 | | | | | | | | | 住所 | 北京市海淀区闵庄路 | | | | | | | | | 权益变动时间 | | | | 信息披露义务人杨永松先生因自身资金需求，于 | | | 2025 年 | 6 月 | | 5 | | | | 日通过集中竞价交易减持公司股份 | 2,246,000 | | 股，占公司总 | | | 股本的 | | | | 0.47%，持有公司股份比例由 | 8.38%下降至 | | | 7.91%，变 | | 动触及 | | 1%的整数倍。本次减持严格按照已披露的《关于持股 | | | | | | | | | | 5%以上股东及董事、高管减持股份预披露公告》中的相关计 | | | | | | | | | | 划。杨永松先生不是公司控股股东、实际控制人，未在公司任 | | | | | ...

Core Viewpoint - The storage chip sector is experiencing significant stock price movements, with several companies seeing sharp increases due to a new wave of price hikes in the market [1] Group 1: Market Movements - Goodix Technology's stock surged to the daily limit, indicating strong investor interest [1] - Other companies such as Zhaoyi Innovation and Xinyu Ren also saw their stocks rise over 5% [1] - Additional companies including Tongyou Technology, Yingfang Micro, Wanrun Technology, and Shannon Chip Innovation followed suit with price increases [1] Group 2: Market Trends - The storage chip market is currently undergoing a new round of price increases, with multiple leading firms announcing higher prices for certain products [1]